Anti-Counterfeit Pharmaceutical and Cosmetic Packaging Market Report 2026

The anti-counterfeit pharmaceutical and cosmetic packaging market size has grown rapidly in recent years. It will grow from $109.37 billion in 2025 to $120.57 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing incidents of counterfeit drugs and cosmetics, strengthening pharmaceutical safety regulations, expansion of global pharmaceutical supply chains, rising brand protection initiatives, growing awareness of consumer safety.

The anti-counterfeit pharmaceutical and cosmetic packaging market size is expected to see rapid growth in the next few years. It will grow to $177.85 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing adoption of blockchain-based authentication, rising investments in smart packaging technologies, expansion of digital health compliance systems, growing regulatory enforcement on serialization, increasing demand for real-time product verification. Major trends in the forecast period include increasing adoption of serialized packaging solutions, rising integration of track-and-trace technologies, growing use of tamper-evident packaging features, expansion of smart labeling systems, enhanced focus on end-to-end supply chain visibility.

The increasing demand for certified medical products is expected to drive the growth of the anti-counterfeit pharmaceutical and cosmetic packaging market in the coming years. Certified medical products are those that have been approved by regulatory authorities for meeting established safety, quality, and performance standards. Heightened regulatory scrutiny aimed at ensuring patient safety is accelerating the demand for certified medical products, as healthcare providers place greater emphasis on compliance, reliability, and quality assurance. Certified pharmaceutical and cosmetic products increasingly rely on anti-counterfeit packaging solutions incorporating features such as QR codes, RFID tags, holograms, and tamper-evident seals to verify authenticity and safeguard product integrity. These technologies enable effective traceability and tamper prevention, while digital tools and blockchain-based systems further enhance supply chain transparency and consumer protection. For instance, in August 2024, according to Graylight Imaging, a Poland-based software company, the U.S. Food and Drug Administration (FDA) expanded its list of AI-enabled medical devices to 950 approved products, marking a substantial increase compared with 2022. Consequently, the growing emphasis on certified medical products is supporting the expansion of the anti-counterfeit pharmaceutical and cosmetic packaging market.

Advancements in holographic packaging are emerging as a key trend in strengthening anti-counterfeit measures within the pharmaceutical and cosmetic sectors. Industry participants are increasingly focusing on the development of advanced solutions such as holographic effects-based packaging materials to enhance product safety and maintain integrity. Holographic packaging leverages sophisticated visual technologies to create distinctive and visually appealing designs that not only improve brand recognition but also serve as an effective deterrent against counterfeiting by providing unique and difficult-to-replicate identifiers. For example, in January 2024, UFLEX LIMITED, an India-based multinational flexible packaging company, introduced a cold-form Alu Alu laminate featuring holographic effects. This solution is specifically designed for pharmaceutical packaging to improve brand visibility while addressing counterfeiting risks through advanced holographic security features. The launch aligns with the company’s broader strategy of integrating enhanced anti-counterfeit technologies alongside sustainable packaging alternatives.

In February 2024, Körber, a Germany-based international technology group, acquired a majority stake in Rondo-Pak for an undisclosed amount. Through this acquisition, Körber aims to reinforce its sustainable pharmaceutical packaging capabilities and broaden its presence across the North American market. Rondo-Pak is a US-based provider specializing in anti-counterfeiting and environmentally friendly packaging solutions for the pharmaceutical and biotechnology industries.

Major companies operating in the anti-counterfeit pharmaceutical and cosmetic packaging market are Avery Dennison Corporation, Chugai Pharmaceutical Co. Ltd., Constantia Flexibles, SICPA, Nosco Inc., Antares Vision Group, Optel Group, Systech, Authentix Inc., Digimarc Corporation, CCL Label, Applied DNA Sciences Inc., SECURIKETT Ulrich & Horn GmbH, Kezzler, Alpvision SA, Covectra, Shriram Veritech Solutions Pvt. Ltd., Hira Holovision, NanoMatriX Technologies Limited, Schreiner MediPharm.

North America was the largest region in the anti-counterfeit pharmaceutical and cosmetic packaging market in 2025. The regions covered in the anti-counterfeit pharmaceutical and cosmetic packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-counterfeit pharmaceutical and cosmetic packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-counterfeit pharmaceutical and cosmetic packaging market consists of revenues earned by entities by providing services such as track and trace solutions, product serialization, smart packaging solutions, packaging design and customization, and supply chain monitoring. The anti-counterfeit pharmaceutical and cosmetic packaging market includes sales of smart labels, UV-sensitive markers, and physical tamper-evident seals. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.